Physician profile
Jay A Mazel
NPI 1851308704
$18,202.54
in general payments reported to CMS, 2019-2025
12 companies · $2,743 in 2025
The $2,743 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,485 · 2020: $238 · 2021: $46.35 · 2022: $170 · 2023: $8,368 · 2024: $5,152 · 2025: $2,743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Food and Beverage: $2,198 · Travel and Lodging: $190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,874.79 |
| Food and Beverage | $2,198.23 |
| Travel and Lodging | $190.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $7,720.99 | 2022-2025 | Carto 3, Octaray Mapping Catheter |
| Medical Device Business Services, INC. | $7,500.00 | 2023-2025 | Carto 3 |
| Medtronic Vascular, INC. | $1,673.35 | 2019-2020 | |
| Medtronic, INC. | $761.91 | 2022-2025 | Micra, Azure Xt Dr Mri Surescan, Selectsecure |
| Atricure, INC. | $144.69 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Abbott Laboratories | $115.74 | 2019-2024 | Perclose Prostyle |
| Cardiva Medical, INC. | $112.71 | 2024-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Astrazeneca Pharmaceuticals Lp | $76.63 | 2023-2024 | |
| Sumitomo Pharma America, INC. | $25.97 | 2025 | Orgovyx |
| Novartis Pharmaceuticals Corporation | $24.77 | 2023 | |
| Novo Nordisk INC | $24.16 | 2023 | Ozempic |
| Kiniksa Pharmaceuticals International, Plc | $21.62 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Mazel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.